Pharmaceutical Executive Digital Edition - August 2012

Piramal Pivots for Growth

Articles in this issue

almost 14 years ago

Article

Country Report: Mexico

almost 14 years ago

Article

Sunny Outlook for Biopharm 2020?

almost 14 years ago

Article

The Phrase that Plays

almost 14 years ago

Article

Planning that Thousand Year Future

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Pharmaceutical Executive Digital Edition - August 2012

Articles in this issue

Related Content

Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena

FDA Pauses Release of New CRL’s Following Citizen’s Petition

FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma

AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial

U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels

Trending on PharmExec

AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial

U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels

FDA Pauses Release of New CRL’s Following Citizen’s Petition

FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma

Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement